Parkers Trading Volume Surges 33.35% Ranking 178th in Stock Market

On May 8, 2025, Parker's trading volume reached 5.51 billion, marking a 33.35% increase from the previous day, ranking 178th in the day's stock market. Parker Hannifin (PH) rose by 2.97%, marking two consecutive days of gains, with a total increase of 4.49% over the past two days.

Parker Hannifin has introduced the BioBLU c HNQ Single-Use Bioreactors, which are rigid-walled stirred-tank bioreactors designed for the cultivation of human and animal cells. These bioreactors are suitable for both clinical and commercial manufacturing, offering a scalable solution with a working volume range from 320 mL to 40 L, enabling over 100-fold cell expansion. The BioBLU c HNQ portfolio includes various sizes, such as the BioBLU 1c HNQ, BioBLU 3c HNQ, BioBLU 10c HNQ, and BioBLU 50c HNQ, each designed for different cell culture applications. Additionally, the BioBLU 5p HNQ Single-Use Bioreactor is specifically designed for the cultivation of adherent cells and perfusion processes, with a fixed working volume of 3.75 L and preloaded with Fibra-Cel Disks for solid growth support.

These bioreactors come with comprehensive validation guides, irradiation certificates, and sterile and endotoxin test reports, ensuring compliance with GMP requirements. The bioreactors are equipped with features such as efficient mixing and mass transfer, clear markings for ease of use, and non-invasive sensor technology to reduce contamination risks. The temperature sensor is inserted into a thermowell for non-invasive measurement, while the dissolved oxygen (DO) sensor port prevents direct contact with the culture medium. The bioreactors also utilize optical pH sensing technology from PreSens, providing an alternative to standard pH sensors.